Improving our understanding of the mechanism of action of SNM could help improve the selection of patients who might benefit from this treatment and potentially allow for improvements in the technology.
Cleveland Clinic urologists evaluate the latest OAB interventions, from nerve stimulation to radiofrequency ablation.
Surgery for stress urinary incontinence can reduce overactive bladder symptoms, but the level of improvement decreases over time and can be blunted by obesity, a recent analysis reports.
This ‘fitness tracker for the bladder,’ now in preclinical testing, has the potential to eliminate the need for urodynamics and the discomfort and inconvenience it entails.
BOTOX® injections are just as safe for overactive bladder patients age 80 and up. A new study shows same low complication rates as in younger patients.
When medications and exercise are not effective at managing overactive bladder, pelvic stimulation devices are a good option. A women’s health specialist explains the best approach to prescribing them.
Overactive bladder guidelines call for following hierarchical treatment of patients, with correction of prolapse the next step for patients who fail modifiable and medical interventions.
Receiving the implant as part of a clinical trial in 1991, the now 81-year-old patient has been able to urinate normally with no additional treatment aside from battery changes every few years.
Laser and estrogen therapies are similarly effective treatments for genitourinary syndrome of menopause, according to a recently published, multi-institutional trial. Gynecologist and principal investigator Marie Fidela Paraiso, MD, discusses the trial and the setbacks the team has encountered, despite the positive results.
Please join our staff as we participate or present in the following presentations at the 2019 AUA Annual Meeting.